Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7171)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2020 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Roth GS, Teyssier Y, Abousalihac M, Seigneurin A, Ghelfi J, Sengel C, Decaens T. Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma. World J Gastroenterol 2020; 26(3): 324-334 [PMID: 31988592 DOI: 10.3748/wjg.v26.i3.324] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v26/i3/324.htm |
| Number | Citing Articles |
| 1 |
Gaël S. Roth, Maxime Benhamou, Yann Teyssier, Arnaud Seigneurin, Mélodie Abousalihac, Christian Sengel, Olivier Seror, Julien Ghelfi, Nathalie Ganne-Carrié, Lorraine Blaise, Olivier Sutter, Thomas Decaens, Jean-Charles Nault. Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis. Cancers 2021; 13(4): 812 doi: 10.3390/cancers13040812
|
| 2 |
Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim. Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association. Journal of Liver Cancer 2023; 23(2): 241 doi: 10.17998/jlc.2023.05.22
|
| 3 |
Rita Golfieri, Mario Bezzi, Gontran Verset, Fabio Fucilli, Cristina Mosconi, Alberta Cappelli, Alexandro Paccapelo, Pierleone Lucatelli, Nicolas Magand, Agnes Rode, Thierry De Baere. Retrospective European Multicentric Evaluation of Selective Transarterial Chemoembolisation with and without Balloon-Occlusion in Patients with Hepatocellular Carcinoma: A Propensity Score Matched Analysis. CardioVascular and Interventional Radiology 2021; 44(7): 1048 doi: 10.1007/s00270-021-02805-5
|
| 4 |
Enhao Lu, Guoliang Shao, Jingqin Ma, Yiwei He, Yuanchuan Gong, Zhiping Yan, Xianyi Sha. Optimized Loading of Idarubicin in CalliSpheres® Drug-Eluting Beads and Characterization of Release Profiles and Morphological Properties. Pharmaceutics 2021; 13(6): 799 doi: 10.3390/pharmaceutics13060799
|
| 5 |
Hong‐Wei Lei, Bi‐Run Huang, Jie Cai, Cheng‐Ming Li, Chun‐Bo Shang, Zhi‐Yang Liao, Zheng‐Dong Wan. CXCR4 antagonist AMD3100 enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma. The Kaohsiung Journal of Medical Sciences 2022; 38(8): 781 doi: 10.1002/kjm2.12540
|
| 6 |
Sofi Sennefelt Nyman, Håkan Ahlström, Angeliki Dimopoulou Creusen, David Dahlgren, Mikael Hedeland, Femke Heindryckx, Ulf Johnson, Jaafar Khaled, Fredrik Kullenberg, Rickard Nyman, Fredrik Rorsman, Reza Sheikhi, Ulrika S H Simonsson, Erik Sjögren, Alkwin Wanders, Hans Lennernäs, Charlotte Ebeling Barbier. Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival. BMJ Open 2022; 12(11): e065839 doi: 10.1136/bmjopen-2022-065839
|
| 7 |
Charlotte Ebeling Barbier, Femke Heindryckx, Hans Lennernäs. Limitations and Possibilities of Transarterial Chemotherapeutic Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(23): 13051 doi: 10.3390/ijms222313051
|
| 8 |
Prateek Pathak, Vikas Kumar, Habibullah Khalilullah, Maria Grishina, HariOm Singh, Amita Verma. Debelalactone Prevents Hepatic Cancer via Diminishing the Inflammatory Response and Oxidative Stress on Male Wistar Rats. Molecules 2022; 27(14): 4499 doi: 10.3390/molecules27144499
|
| 9 |
Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim. Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association. Clinical and Molecular Hepatology 2023; 29(3): 521 doi: 10.3350/cmh.2023.0202
|
| 10 |
Gael S. Roth, Olivier Hernandez, Najeh Daabek, Bleuenn Brusset, Yann Teyssier, Julien Ghelfi, Marie Noelle Hilleret, Christian Sengel, Ivan Bricault, Thomas Decaens, Charlotte Costentin. Safety and Efficacy of Transarterial Chemoembolization in Elderly Patients with Intermediate Hepatocellular Carcinoma. Cancers 2022; 14(7): 1634 doi: 10.3390/cancers14071634
|
| 11 |
Gael Roth, Yann Teyssier, Maxime Benhamou, Mélodie Abousalihac, Stefano Caruso, Christian Sengel, Olivier Seror, Julien Ghelfi, Arnaud Seigneurin, Nathalie Ganne-Carrie, Elia Gigante, Lorraine Blaise, Olivier Sutter, Thomas Decaens, Jean-Charles Nault. Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization. World Journal of Gastroenterology 2022; 28(36): 5324-5337 doi: 10.3748/wjg.v28.i36.5324
|
| 12 |
Chenghao Zhao, Huzheng Yan, Zhanwang Xiang, Haofan Wang, Mingan Li, Mingsheng Huang. Idarubicin versus epirubicin in drug-eluting beads-transarterial chemoembolization for treating hepatocellular carcinoma: A real-world retrospective study. Investigational New Drugs 2023; 41(4): 617 doi: 10.1007/s10637-023-01377-0
|
| 13 |
Mohammed S. Saddik, Mahmoud M. A. Elsayed, Amany A. Abdel-Rheem, Mohamed A. El-Mokhtar, Eisa S. Mosa, Mostafa F. Al-Hakkani, Samah A. Al-Shelkamy, Ali Khames, Mohamed A. Daha, Jelan A. Abdel-Aleem. A Novel C@Fe@Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma. Pharmaceutics 2022; 14(9): 1845 doi: 10.3390/pharmaceutics14091845
|
| 14 |
Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim. Transarterial Chemoembolization for Hepatocellular Carcinoma: 2023 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association. Korean Journal of Radiology 2023; 24(7): 606 doi: 10.3348/kjr.2023.0385
|
| 15 |
Lingwei Liu, Jialang Zhuang, Jizhou Tan, Ting Liu, Wenzhe Fan, Yuanqing Zhang, Jiaping Li. Doxorubicin-Loaded UiO-66/Bi2S3 Nanocomposite-Enhanced Synergistic Transarterial Chemoembolization and Photothermal Therapy against Hepatocellular Carcinoma. ACS Applied Materials & Interfaces 2022; 14(6): 7579 doi: 10.1021/acsami.1c19121
|
| 16 |
Thierry de Baere, Boris Guiu, Maxime Ronot, Patrick Chevallier, Géraldine Sergent, Illario Tancredi, Lambros Tselikas, Marco Dioguardi Burgio, Lucas Raynaud, Frederic Deschamps, Gontran Verset. Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry. Cancers 2020; 12(11): 3405 doi: 10.3390/cancers12113405
|
| 17 |
Zhiying Zheng, Mingxi Ma, Xiuping Han, Xiao Li, Jinxin Huang, Yuetong Zhao, Hanyuan Liu, Junwei Kang, Xiangyi Kong, Guoqiang Sun, Guangshun Sun, Jie Kong, Weiwei Tang, Guoqiang Shao, Fei Xiong, Jinhua Song. Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma. Acta Biomaterialia 2023; 157: 337 doi: 10.1016/j.actbio.2022.12.004
|
| 18 |
Lisa S. Parks, Patricia Little. Cirrhosis, Hepatocellular Carcinoma, and Locoregional Therapies. Journal of Radiology Nursing 2022; 41(2): 129 doi: 10.1016/j.jradnu.2022.01.005
|